| Category : |
Pharmaceuticals and Biochemicals |
 |
| CAS NO : |
135459-87-9 |
| EC NO : |
|
| MF : |
C12H20N2O15SSr2 |
| MW : |
639.5966 |
| Packing : |
1kg/bag |
| Product description : |
Molecular Formula ：C12H20N2O15SSr2
Molecular Weight：639.5966
Physical Character:Off-white to yellowish crystalline powder
Executive standard：Draft Specification of Strontium Ranelate for CFDA Submission
pH 6.5～8.5
Related Substances Impurity Ａ≤0.5% Single Impurity≤0.05%
Total Impurities≤1.0%
Strontium Ranelate Ethyl Ester ≤0.2%
Residual Solvents Acetone：≤0.05% Ethanol：≤0.05% Loss on Drying 18.0% ～22.0%
Heavy Metals ≤0.002%
Assay (Calculated on dried basis) 98.0% ～102.0%
Strontium (Calculated on dried basis) 30.7～37.5% |
| Uses : |
Mainly used for the treatment and prevention of osteoporosis in postmenopausal women, significantly reduce the risk of vertebral fractures and hip fractures. |
| Synonyms : |
Distrontium renelate;5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt;STRONCIUM RANELATE;5-[bis(carboxymethyl)amino]-3-(carboxymethyl)-4-cyanothiophene-2-carboxylic acid;strontium 5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate hydrate (2:1:7);Ranelate Strontium;5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt (1:2); |
| Molecular Structure : |
 |